Publicación:
Levosimendan en disfunción ventricular en el posoperatorio de cirugía cardíaca. Hospital Santa Clara de Bogotá D.C. Octubre 2011 a Septiembre 2012

Vista sencilla de ítem
dc.contributor.authorBadillo, Expeditospa
dc.contributor.authorHennessey, José Maríaspa
dc.contributor.authorSantis, Edward Alonsospa
dc.date.accessioned2015-12-01 00:00:00
dc.date.accessioned2022-02-21T20:38:01Z
dc.date.available2015-12-01 00:00:00
dc.date.available2022-02-21T20:38:01Z
dc.date.issued2015-12-01
dc.format.mimetypeapplication/pdfspa
dc.identifier.doi10.31260/RepertMedCir.v24.n4.2015.601
dc.identifier.eissn2462-991X
dc.identifier.issn0121-7372
dc.identifier.urihttps://repositorio.fucsalud.edu.co/handle/001/2491
dc.identifier.urlhttps://doi.org/10.31260/RepertMedCir.v24.n4.2015.601
dc.language.isospaspa
dc.publisherSociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Saludspa
dc.relation.bitstreamhttps://revistas.fucsalud.edu.co/index.php/repertorio/article/download/601/639
dc.relation.citationeditionNúm. 4 , Año 2015 : Octubre – Diciembrespa
dc.relation.citationendpage283
dc.relation.citationissue4spa
dc.relation.citationstartpage275
dc.relation.citationvolume24spa
dc.relation.ispartofjournalRevista Repertorio de Medicina y Cirugíaspa
dc.relation.referencesHiggins TL, Estafanous FG, Loop FD, Beck GJ, Blum JM, Paranandi L. Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients. A clinical severity score. JAMA. 1992;267(17):2344-8. Epub 1992/05/06.spa
dc.relation.referencesEslava-Schmalbach JH, Rincón CJ, Guarnizo CC. “Inequidad” de la expectativa de vida al nacer por sexo y “departamentos” de Colombia. Biomédica; Vol 33, núm 3 (2013). doi: 10.7705/biomedica.v33i3.811.spa
dc.relation.referencesDelgado JF. [Levosimendan in acute heart failure: past, present and future]. Rev Esp Cardiol. 2006;59(4):309-12. Epub 2006/05/20. Levosimendan en la insuficiencia cardíaca aguda: pasado, presente y futuro.spa
dc.relation.referencesBreisblatt WM, Stein KL, Wolfe CJ, Follansbee WP, Capozzi J, Armitage JM, et al. Acute myocardial dysfunction and recovery: a common occurrence after coronary bypass surgery. J Am Coll Cardiol. 1990;15(6):1261-9. Epub 1990/05/01.spa
dc.relation.referencesPollesello P, Mebazaa A. ATP-dependent potassium channels as a key target for the treatment of myocardial and vascular dysfunction. Curr Opin Crit Care. 2004;10(6):436-41. Epub 2004/12/24.spa
dc.relation.referencesGarlid KD, Dos Santos P, Xie ZJ, Costa AD, Paucek P. Mitochondrial potassium transport: the role of the mitochondrial ATP-sensitive K(+) channel in cardiac function and cardioprotection. Biochim Biophys Acta. 2003;1606(1-3):1-21. Epub 2003/09/26.spa
dc.relation.referencesMalliotakis P, Xenikakis T, Linardakis M, Hassoulas J. Haemodynamic effects of levosimendan for low cardiac output after cardiac surgery: a case series. Hellenic J Cardiol. 2007;48(2):80-8. Epub 2007/05/11.spa
dc.relation.referencesNashef SAM. European system for cardiac operative risk evaluation (EuroSCORE). European Journal of Cardio - Thoracic Surgery. 1999;16(1):4.spa
dc.relation.referencesMangano DT. Biventricular function after myocardial revascularization in humans: deterioration and recovery patterns during the first 24 hours. Anesthesiology. 1985;62(5):571-7. Epub 1985/05/01.spa
dc.relation.referencesTamargo J, Lopez-Sendon J. [Rationale and clinical evidence for the effects of new pharmacological treatments for heart failure]. Rev Esp Cardiol. 2004;57(5):447-64. Epub 2004/05/21. Bases y evidencias clinicas de los efectos de los nuevos tratamientos farmacologicos en la insuficiencia cardíaca.spa
dc.relation.referencesMoiseyev VS, Poder P, Andrejevs N, Ruda MY, Golikov AP, Lazebnik LB, et al. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN). Eur Heart J. 2002;23(18):1422-32. Epub 2002/09/05.spa
dc.relation.referencesBenlolo S, Lefoll C, Katchatouryan V, Payen D, Mebazaa A. Successful use of levosimendan in a patient with peripartum cardiomyopathy. Anesth Analg.2004;98(3):822-4, table of contents. Epub 2004/02/26.spa
dc.relation.referencesCheung EH, Arcidi JM, Jr., Dorsey LM, Vinten-Johansen J, Hatcher CR, Jr., Guyton RA. Reperfusion of infarcting myocardium: benefit of surgical reperfusion in a chronic model. Ann Thorac Surg. 1989;48(3):331-8. Epub 1989/09/01.spa
dc.relation.referencesVinten-Johansen J, Chiantella V, Johnston WE, Jolly BT, Kendricks WD, Hester TO, et al. Adjuvant N-(2-mercaptopropionyl)-glycine in blood cardioplegia does not improve myocardial protection in ischemically damaged hearts. J Thorac Cardiovasc Surg. 1990;100(1):65-76. Epub 1990/07/01.spa
dc.relation.referencesYokoyama H, Julian JS, Vinten-Johansen J, Johnston WE, Smith TD, McGee DS, et al. Postischemic [Ca2+] repletion improves cardiac performance without altering oxygen demands. Ann Thorac Surg. 1990;49(6):894-902. Epub 1990/06/01.spa
dc.relation.referencesCunningham JN, Jr., Adams PX, Knopp EA, Baumann FG, Snively SL, Gross RI, et al. Preservation of ATP, ultrastructure, and ventricular function after aortic cross-clamping and reperfusion. Clinical use of blood potassium cardioplegia. J Thorac Cardiovasc Surg. 1979;78(5):708-20. Epub 1979/11/01.spa
dc.relation.referencesOpie LH. The heart: physiology, from cell to circulation: Lippincott-Raven; 1998 1998. 637 p.spa
dc.relation.referencesKevin LG, Novalija E, Stowe DF. Reactive oxygen species as mediators of cardiac injury and protection: the relevance to anesthesia practice. Anesth Analg.2005;101(5):1275-87. Epub 2005/10/26.spa
dc.relation.referencesKloner RA, Jennings RB. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 2. Circulation. 2001;104(25):3158-67. Epub 2001/12/19.spa
dc.relation.referencesFollath F, Cleland JG, Just H, Papp JG, Scholz H, Peuhkurinen K, et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet. 2002;360(9328):196-202. Epub 2002/07/23.spa
dc.relation.referencesLuu M, Stevenson LW, Brunken RC, Drinkwater DM, Schelbert HR, Tillisch JH. Delayed recovery of revascularized myocardium after referral for cardiac transplantation. Am Heart J. 1990;119(3 Pt 1):668-70. Epub 1990/03/01.spa
dc.relation.referencesGreenberg B, Borghi C, Perrone S. Pharmacotherapeutic approaches for decompensated heart failure: a role for the calcium sensitiser, levosimendan? Eur J Heart Fail. 2003;5(1):13-21. Epub 2003/02/01.spa
dc.relation.referencesAlvarez J, Bouzada M, Fernandez AL, Caruezo V, Taboada M, Rodriguez J, et al. [Hemodynamic effects of levosimendan compared with dobutamine in patients with low cardiac output after cardiac surgery]. Rev Esp Cardiol. 2006;59(4):338-45. Epub 2006/05/20. Comparacion de los efectos hemodinamicos del levosimendan con la dobutamina en pacientes con bajo gasto despues de cirugia cardíaca.spa
dc.relation.referencesLevin RL, Degrange MA, Porcile R, Salvagio F, Blanco N, Botbol AL, et al. [The calcium sensitizer levosimendan gives superior results to dobutamine in postoperative low cardiac output syndrome]. Rev Esp Cardiol. 2008;61(5):471-9. Epub 2008/05/09. Superioridad del sensibilizante al calcio levosimendan comparado con dobutamina en el sindrome de bajo gasto cardíaco postoperatorio.spa
dc.relation.referencesGarcia Gonzalez MJ, Dominguez Rodriguez A. Pharmacologic treatment of heart failure due to ventricular dysfunction by myocardial stunning: potential role of levosimendan. Am J Cardiovasc Drugs. 2006;6(2):69-75. Epub 2006/03/25.spa
dc.relation.referencesRaja SG, Rayen BS. Levosimendan in cardiac surgery: current best available evidence. Ann Thorac Surg. 2006;81(4):1536-46. Epub 2006/03/28.spa
dc.relation.referencesLilleberg J, Nieminen MS, Akkila J, Heikkila L, Kuitunen A, Lehtonen L, et al. Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting. Eur Heart J. 1998;19(4):660-8. Epub 1998/05/23.spa
dc.rightsFundación Universitaria de Ciencias de la Salud FUCS - 0spa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2spa
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/spa
dc.sourcehttps://revistas.fucsalud.edu.co/index.php/repertorio/article/view/601spa
dc.subjectlevosimendanspa
dc.subjectdisfunción ventricularspa
dc.subjectfracción de eyecciónspa
dc.subjectlevosimendaneng
dc.subjectventricular dysfunctioneng
dc.subjectejection fractioneng
dc.titleLevosimendan en disfunción ventricular en el posoperatorio de cirugía cardíaca. Hospital Santa Clara de Bogotá D.C. Octubre 2011 a Septiembre 2012spa
dc.title.translatedLevosimendan in ventricular dysfunction in the postoperative period of cardiac surgery. Hospital Santa Clara de Bogotá D.C. October 2011 to September 2012eng
dc.typeArtículo de revistaspa
dc.typeJournal articleeng
dc.type.coarhttp://purl.org/coar/resource_type/c_6501spa
dc.type.coarversionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.type.contentTextspa
dc.type.driverinfo:eu-repo/semantics/articlespa
dc.type.versioninfo:eu-repo/semantics/publishedVersionspa
dspace.entity.typePublication

Archivos

Colecciones

BA. Revista Repertorio